Discover and read the best of Twitter Threads about #qNIV
Most recents (1)
We’re proud to announce the publication of our successful Phase 3 trial of NanoFlu™, our seasonal quadrivalent Nanoparticle #Influenza #Vaccine (#qNIV) candidate, in @TheLancetInfDis. Let’s dig into why it matters: thelancet.com/journals/lanin…
Thread:
Thread:
According to @CDC, “on average, about 8% of the U.S. population gets sick from #flu each season.” There is an urgent need for improved flu #vaccines, particularly for older adults (>age 65), who bear higher disease burden. cdc.gov/flu/about/keyf…
Coverage of existing flu vaccines is >60% in the US, but recent flu seasons have shown vaccine effectiveness may be just 10-13% for one virus strain (A/H3N2) in older adults. ncbi.nlm.nih.gov/pmc/articles/P…
